Alpenglow Biosciences, Inc. — Form D
Alpenglow Biosciences, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-25. The offering totals $4.8M, of which $1.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-03-25
- Form: D
- Accession: 0001763787-24-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.8M
- Amount sold: $1.8M
- Remaining: $3.0M
- Investors: 4
- Date of first sale: 2024-03-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-508493
Issuer
- Name: Alpenglow Biosciences, Inc.
- CIK: 0001763787
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2121 N 35TH STREET, SUITE 100, SEATTLE, WA, 98103
- Phone: 206-659-7920
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Alex TC Springer | Executive Officer | Seattle, WA |
| Daniella TC Kranjac | Director | Seattle, WA |
| Jonathan TC Liu | Director | Seattle, WA |
| Michael TC Dutton | Executive Officer | Seattle, WA |
| Gustavo TC Mahler | Director | Seattle, WA |
| Jonathan G Liu | Director | Redmond, WA |
| Nicholas P Reder | Director | Redmond, WA |
| Nicholas P Reder | Executive Officer | Redmond, WA |
| Steven G Buckley | Director | Redmond, WA |
| Steven G Buckley | Executive Officer | Redmond, WA |
Other filings by this issuer (4)
More